[HTML][HTML] Antibiotic treatment and survival in non-small cell lung cancer patients receiving immunotherapy: a systematic review and meta-analysis
A Abdelhamid, S Tuminello, T Ivic-Pavlicic… - Translational Lung …, 2023 - ncbi.nlm.nih.gov
Background In patients with non-small cell lung cancer (NSCLC), immune checkpoint
inhibitors (ICIs) are an effective mode of treatment. Despite their efficacy, responses to ICIs …
inhibitors (ICIs) are an effective mode of treatment. Despite their efficacy, responses to ICIs …
[HTML][HTML] Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma
S Acharya, C Thirunavukkarasu - Frontiers in Bioscience-Landmark, 2024 - imrpress.com
The body of a human has a vast array of microorganisms termed the microbiome that
impacts almost every function of the body. Gene-environment interactions play a major role …
impacts almost every function of the body. Gene-environment interactions play a major role …
[HTML][HTML] Assessing the impact of COVID-19 on prescription patterns and antibiotic use: Insights from three military health facilities
Background The COVID-19 pandemic disrupted health systems globally and there are
suggestions it impacted antibiotics prescribing patterns in clinical practice. Objectives This …
suggestions it impacted antibiotics prescribing patterns in clinical practice. Objectives This …
Association Between Antibiotic and Outcomes of Chemoimmunotherapy for Extensive‐Stage Small Cell Lung Cancer: A Multicenter Retrospective Study of 132 …
F Deng, H Ye, P Zhang, J Xu, Y Li, M Sun… - Thoracic …, 2025 - Wiley Online Library
Introduction To evaluate the impact of antibiotic (ATB) exposure on the outcome of
chemoimmunotherapy in patients with extensive‐stage small cell lung cancer (ES‐SCLC) …
chemoimmunotherapy in patients with extensive‐stage small cell lung cancer (ES‐SCLC) …
Impact of Antibiotic on Efficacy and Adverse Reactions of Chemoimmunotherapy in Non‐small Cell Lung Cancer Patients: A Retrospective Cohort Study
F Deng, X Du, P Zhang, J Xu, Y Li, Z Yang - Thoracic Cancer, 2024 - Wiley Online Library
Background This study aimed to evaluate the impact of antibiotic exposure on efficacy and
adverse reactions in non‐small cell lung cancer (NSCLC) patients receiving …
adverse reactions in non‐small cell lung cancer (NSCLC) patients receiving …
The Effects of Antibiotics on the Development and Treatment of Non-Small Cell Lung Cancer
P Švecová, P Jakubec, J Škarda… - Polish Journal of …, 2023 - sciendo.com
There have been studies on antibiotic use concerning lung cancer and its potential impact
on carcinogenesis and microbiome. However, subsequent research has failed to support …
on carcinogenesis and microbiome. However, subsequent research has failed to support …
Assessing the impact of COVID-19 on prescription patterns and antibiotic use: Insights from three military health facilities
BO Ukoha-Kalu, MM Abubakar… - … in Social and … - nottingham-repository.worktribe.com
Background: The COVID-19 pandemic disrupted health systems globally and there are
suggestions it impacted antibiotics prescribing patterns in clinical practice. Objectives: This …
suggestions it impacted antibiotics prescribing patterns in clinical practice. Objectives: This …
Analisi nella Pratica Clinica delle possibili interazioni tra Antibiotici ed Inibitori dei Checkpoint Immunitari in pazienti oncologici
G BRESSAN - thesis.unipd.it
Il progetto di Tesi ha come obiettivo l'analisi retrospettiva degli effetti delle interazioni tra
Antibiotici e Inibitori dei Checkpoint Immunitari (ICIs) nei pazienti oncologici che sono stati …
Antibiotici e Inibitori dei Checkpoint Immunitari (ICIs) nei pazienti oncologici che sono stati …